Christina A. Bachmeier

Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma

Michael D. Jain, Hua Zhao, Xuefeng Wang et al. · Blood · 2021 · 292 citations · Full text

Medicine, Immunology, Oncology +17

Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma

Jennifer M. Logue, Elisa Zucchetti, Christina A. Bachmeier et al. · Haematologica · 2020 · 271 citations · Full text

Medicine, Hematology, Oncology +17

High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma

Erin Dean, Rahul Mhaskar, Hong Lü et al. · Blood Advances · 2020 · 242 citations · Full text

Medicine, Oncology, Pharmacology +17

Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel

Rawan Faramand, Michael D. Jain, Verena Staedtke et al. · Clinical Cancer Research · 2020 · 83 citations · Full text

Medicine, Immunology, Oncology +17

Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion

Kai Rejeski, Ariel Perez Perez, Gloria Iacoboni et al. · Science Advances · 2023 · 59 citations · Full text

Life Sciences, Hematology, Immunology +16